Home
Soleus Capital Master Fund reported a 5% stake in UroGen Pharma URGN · 2,325,000 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5%
- Last report
- First report
- Shares held
- 2,325,000 sh
- Class
- Ordinary Shares, par value NIS 0.01 per share
- Stock
- UroGen Pharma URGN
- Event date
- 25/06/13
- Filed
- 25/06/16
First 5%+ report · 5% stake
UroGen Pharma trades, last 26 weeks
What else happened in UroGen Pharma around then
Filed or reported within 30 days of the trade day · 25/05/14~25/07/13Soleus Capital Master Fund's other 5% stake reports
- Soleus Capital Master Fund
5% stakeEvolus
5% stakeEvolus
EOLS
5.3% stake
3,480,000 sh
5.3% stake
Filed 08/31
- Soleus Capital Master Fund
5% stakeProcessa Pharmaceuticals
5% stakeProcessa Pharmaceuticals
PCSA
5.8% stake
160,943 sh
5.8% stake
Filed 08/18
- Soleus Capital Master Fund
5% stakeInspire Medical Systems
5% stakeInspire Medical Systems
INSP
6.7% stake
1,931,436 sh
6.7% stake
Filed 08/13
- Soleus Capital Master Fund
5% stakePalisade Bio
5% stakePalisade Bio
PALI
7.5% stake
13,063,687 sh
7.5% stake
Filed 08/13
- Soleus Capital Master Fund
5% stakeRigel Pharmaceuticals
5% stakeRigel Pharmaceuticals
RIGL
9.9% stake
1,843,504 sh
9.9% stake
Filed 08/13
